HNN3.0
Register
Register
Register

Project cooperationUpdated on 15 January 2026

Early diagnostis potential of a new technology targeting circulating nano-objects in biofluids

Chief Business Development Officer at HEKAT

Bordeaux, France

About

After 3 years of developpement, HEKAT is seeking for academic and industrial partners to challenge its proprietary technology in real life conditions.

Partners will be academic teams, clinicians or industrial with strong interest in nano-objects (e.g. EVs or viruses) detection and comprehension. Ideally partners will be bring scientific expertise and relevant human biological samples (blood, urines, CSF...). HEKAT will bring optofluidic knowledge and equipments.

Relationship: a WIN-WIN projects allowing researchers to get access to a new resolution in their objects of interest and new avenues for applied sciences and clinical applications (diagnosis, stratification, target engagement, monitoring).

Similar opportunities

  • Project cooperation

    Bridging the Gap in Multiple Sclerosis: From Genetic Isolate to Digital Movement Biomarkers

    Eleonora Cocco

    Full Professor at University of Cagliari (UNICA)

    Cagliari, Italy

  • Project cooperation

    Brain Health

    • Partner seeks Consortium/Coordinator
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Aisling Loftus

    International Funding Officer at FutureNeuro Research Ireland Centre for Translational Brain Science

    Dublin, Ireland

  • Project cooperation

    Validated AI-based SAMD to Personalize Post-Hospital Care Pathways in Chronic Heart Failure

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems

    Grégoire MERCIER

    Co-founder at KanopyMed

    Jacou, France